MSH2 loss caused by TP53 mutation and cortisol hypersecretion caused by CTNNB1 mutations were identified in a metastatic cancer cell line with aldosterone-secreting ACC and Lynch syndrome [162]. Here, TP53 is linked to adrenal cortex carcinoma.